Chinese Agencies’ Agreement Could Halve Approval Time For U.S. Devices

Chinese approval time for imported medical devices could be cut in half under an agreement to reduce redundancies between the country's Administration of Quality Supervision, Inspection and Quarantine (AQSIQ) and its State Food and Drug Administration (SFDA)

More from Archive

More from Medtech Insight